approved EB-2 (NIW)

Postdoctoral Scholar

Biomedical Life Sciences · Ethiopia · 2025-03-13

Processing Time
64 days
Decision Date
2025-03-13
Location
Tennessee
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to advance innovative immunization strategies and translational studies aimed at developing effective vaccines and therapeutics targeting infectious pathogens. The work focuses on investigating host-pathogen interactions and the underlying mechanisms of protective immune responses to strengthen public health systems.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The research on host-pathogen interactions and vaccine development was recognized for its significant merit and importance to global public health efforts.

2 Well-positioned to Advance the Endeavor Met

The petitioner's Ph.D. and extraordinary record of over 25,000 citations demonstrated they are exceptionally well-positioned to lead this research.

3 Balance of Interests Met

The USCIS concluded that the petitioner's high level of influence in the field made it beneficial to waive the labor certification requirement.

Why This Petition Was Approved

The petition was approved based on the petitioner's Ph.D. in health technology and informatics and a record of 18 peer-reviewed journal articles. A critical factor was the extraordinary citation count of 25,515, which placed the petitioner among the most influential researchers in clinical medicine. Additionally, the petitioner provided evidence of 6 peer reviews for respected journals, satisfying all three Dhanasar prongs.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Judging Experience
Original Contributions

Similar Cases

Postdoctoral Researcher

Biotechnology · India

WeGreened EB-2 (NIW) approved
Massachusetts 30 days 2025-06-07
The petitioner proposes to develop and apply advanced immunological and virological methodologies to investigate viral persistence and immune response mechanisms. The work specifically focuses on chronic diseases such as HIV and Epstein-Barr Virus (EBV) to advance therapeutic strategies and vaccine development. This research aims to lower disease burdens and improve public health outcomes by addressing infectious disease control.

Scientist

Biotechnology · India

WeGreened EB-2 (NIW) approved
Pennsylvania 64 days 2025-11-26
The petitioner proposes to continue research on the fundamental mechanisms of cellular stress response and immune system function to advance vaccine development and biotherapeutics. The work utilizes antibody engineering and advanced sequencing technologies to create practical innovations for protecting vulnerable populations from respiratory infections. The intended impact is to address nationwide public health challenges and improve national health security through immediate therapeutic potential.

Others

Biotechnology · India

WeGreened EB-2 (NIW) approved
Maryland 92 days 2023-02-09
The petitioner proposes to continue her research in vaccine development and clinical trial quality control, specifically focusing on how vaccine regimens affect the immune system and the mechanisms regulating vaccine protection. Her work aims to fundamentally transform vaccine development approaches for infectious diseases such as tuberculosis and HIV.

Postdoctoral Researcher

Biotechnology · India

WeGreened EB-2 (NIW) approved
Florida 5 days 2024-07-30
The petitioner proposes to continue researching viral pathogenesis and host-virus interactions to unravel the mechanisms of viral replication, transmission, and pathogenesis. This work aims to design vaccines, antiviral drugs, and diagnostic tools to combat viral threats and mitigate pandemics.

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-03-13.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 64 days
Criteria Met 3 / 3
Evidence Types 4

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,895
Success Rate 54.2%
Sustained 2,112
Dismissed 1,687

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist